(4-(Cyclopropylmethoxy)phenyl)boronic acid, 95.0%, 5g

2,6-Diiodopyridine, 95.0%, 100mg

2-(2-(Allyloxy)ethoxy)ethan-1-ol, 95%, 1g

N-(2-Dimethylaminoethyl)-3-(4,4,5,5-tetramethyl)1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 1g

Methyl 4-cyano-2-fluoro-5-nitrobenzoate, 95.0%, 1g

(S)-(5-Azaspiro[2.4]heptan-6-yl)methanol hydrochloride, 95%, 250mg

Stopper with standard taper plastic, 45/40, 1 Piece

3-methyl-1-(1,3-thiazol-2-yl)piperazine, 95.0%, 2g

Refractometer for Clinical Applications. Analog

5-methyl-2-methylidene-4-oxooxolan-3-yl butanoate, 98%, 100g

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 1g

Sodium Diphenylamine-4-sulfonate>97.0%(HPLC)(N)25g

5-Methyl-4-(methylthio)pyrrolo[2,1-f][1,2,4]triazine, 95.0%, 500mg